There were 42 press releases posted in the last 24 hours and 147,897 in the last 365 days.

Genome Editing Market 2016 Analysis and Forecast to 2020

Genome Editing Market 2016 Share, Trend, Segmentation and Forecast to 2020

PUNE, INDIA, September 21, 2016 /EINPresswire.com/ -- Ever since the establishment of the genetic basis of life, researchers have tried to manipulate genes in plants and animals to improve traits. There has been a continuous evolution of gene modification technique starting from restriction endonucleases, transgenic breeding, RNAi technologies to the current engineered endonucleases. Over the last several decades, technologies for identification, isolation, sequencing, replication and integration of desired genes in target organisms have transformed tremendously and emerged as one of the exciting and significant areas of scientific endeavour.

Complete report details @ https://www.wiseguyreports.com/reports/647745-genome-editing-global-market-forecast-to-2022

The Genome editing global market is segmented based on technology, applications, products, end users and geography. Technologies segment consists of Zinc Finger Nucleases (ZFN), Transcriptor-activator-like effector nuclease (TALEN); Clustered regularly interspaced short palindromic repeats (CRISPR) and other gene modification techniques such as Recombinant adeno-associated virus (rAAV), piggyBac transposon, megatales etc. Applications identified includes, basic research, agriculture biotechnology, animal research, drug discovery and development. Products are classified into reagents, enzymes and consumables, instruments, cell lines & animal models and software. Depending on the end users, the genome editing global market is sectioned into academic & government institutions, pharmaceutical & biotechnology companies, plant biotechnology and others.

Request a sample report @ https://www.wiseguyreports.com/sample-request/647745-genome-editing-global-market-forecast-to-2022

This report studies the genome editing global market over the forecast period 2015 to 2022 and the market is expected to grow at high double digit CAGR to reach $2,669.9 million by 2022. Increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increasing private and public sector funding, rapid advancements in sequencing and gene editing technologies, non-labeling of gene-edited products as Genetically Modified Organisms (GMOs), applications in various drug discovery processes are some of the factors driving the genome editing global market growth. Factors such as stringent regulatory framework, ethical issues concerning editing human embryo and adverse public perception, unavailability of gene-editing based therapeutics in the market, off-target effects of CRISPR and patent disputes associated with CRISPR technology are hampering the market growth.

Geographically, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America dominated the genome editing market with the largest share which is driven by factors such as increasing awareness of technology, proximity of companies, and early adoption of latest treatments. The Asian market is expected to occupy second place due increasing government funding of research, economic prosperity, early adoption of latest technology and the relaxed regulatory environment. The European market is expected to be third largest market, growing at a lower rate mainly due to the stringent regulatory environment and slow growth due to the economic crisis.

The genome editing global market is a consolidated market with key players such as Applied Stemcell (U.S.), Cellectis S.A. (France), Genscript (U.S.), Horizon Discovery Group (U.K.), Merck KGaA (Germany), Origene Technologies (U.S.), Sangamo Biosciences (U.S.), System Biosciences (U.S.), Thermo Fisher Scientific (U,S,), Transposagen (U.S.).

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/647745-genome-editing-global-market-forecast-to-2022

Key Points in Table of Contents
TABLE 1 GENOME EDITING GLOBAL MARKET REVENUE, BY REGION,
(2014-2022) ($MN) 24
TABLE 2 GENOME EDITING GLOBAL MARKET REVENUE, BY TECHNOLOGY TYPE, (2014-2022) ($MN) 78
TABLE 3 ZFN GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 81
TABLE 4 TALEN GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 83
TABLE 5 CRISPR GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 87
TABLE 6 OTHERS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 92
TABLE 7 GENOME EDITING GLOBAL MARKET REVENUE, BY APPLICATION,
(2014-2022) ($MN) 94
TABLE 8 BASIC RESEARCH GLOBAL MARKET REVENUE, BY REGION
(2014-2022) ($MN) 98
TABLE 9 PLANT BIOTECHNOLOGY/AGRICULTURE GLOBAL MARKET REVENUE,
BY REGION (2014-2022) ($MN) 100
TABLE 10 ANIMAL BIOTECHNOLOGY GLOBAL MARKET REVENUE, BY REGION
(2014-2022) ($MN) 103
TABLE 11 DRUG DISCOVERY AND DEVELOPMENT GLOBAL MARKET REVENUE,
BY REGION (2014-2022) ($MN) 104
TABLE 12 DRUG DISCOVERY AND DEVELOPMENT GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 105
TABLE 13 PRE-CLINICAL GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 106
TABLE 14 CLINICAL GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN) 110

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=647745

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here